← Evidence map

TrialJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG2025

A phase IIb single-center study to assess the efficacy of apremilast for the treatment of nummular eczema.

Alexander Böhner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 40548467